Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
FRBN | Forbion European Acquisition Corp. | Director | Dec 9, 2021 | |||
NAMS, NAMSW | NewAmsterdam Pharma Co N.V. | Director | Dec 29, 2023 | |||
REPL | Replimune Group, Inc. | Director | Apr 1, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|